Figure 1From: The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells The cytotoxic activity of LfcinB and KW5 against FEMX melanoma and HT-29 colon carcinoma cells. The dose response curves for LfcinB (A) and KW5 (B) are plotted as percent survival of the cells against different peptide concentrations (μg/ml). The curves correspond to five experiments performed in duplicate ± SEM.Back to article page